𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of combination vincristine, epirubicin and cyclophosphamide in advanced breast cancer in Chinese patients

✍ Scribed by Shiu, W.; Tao, M.; Leung, T.


Book ID
122026118
Publisher
Elsevier Science
Year
1991
Weight
141 KB
Volume
27
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mitoxantrone combined to vincristine, cy
✍ R. Metz; M. Delgado; R. Keiling; P. Cappelaere; J. P. Armand; G. Prevot; J. L. M πŸ“‚ Article πŸ“… 1985 πŸ› Springer US 🌐 English βš– 301 KB

In our wide experience of treating advanced breast carcinoma with chemotherapy, the combination of doxorubicin (DOX), vincristine (VCR), cyclophosphamide (CPM) and fluorouracil (FU) gave a complete plus partial response rate of over 60%, with 100% alopecia and frequent cardiac toxicity depending on